Evaluation of RU28318 and RU40555 as selective mineralocorticoid receptor and glucocorticoid receptor antagonists, respectively: Receptor measures and functional studies

Journal of Steroid Biochemistry and Molecular Biology

Volumn 67, Issue 3, 1998, Pages 213-222

  Kim, Paul J ^a   Cole, Michael A ^a   Kalman, Brian A ^a   Spencer, Robert L ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

17BETA HYDROXY 11 BETA 4 (METHYL)(1 METHYLETHYL)AMINOPHENYL 17ALPHA (PROP 1 YNYL)ESTRA 4,9 DIENE 3 ONE; ALDOSTERONE; DEXAMETHASONE; GLUCOCORTICOID RECEPTOR; GLUCOCORTICOID RECEPTOR ANTAGONIST; MINERALOCORTICOID RECEPTOR; OXPRENOATE POTASSIUM; UNCLASSIFIED DRUG;

ADRENALECTOMY; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; BIOASSAY; CORTICOSTERONE RELEASE; DOSE TIME EFFECT RELATION; DRUG RECEPTOR BINDING; HIPPOCAMPUS; HORMONE RECEPTOR INTERACTION; HYPOPHYSIS; MALE; NONHUMAN; RAT; RECEPTOR BLOCKING; RECEPTOR OCCUPANCY;

ADRENALECTOMY; ALDOSTERONE ANTAGONISTS; ANIMALS; BIOLOGICAL ASSAY; CORTICOSTERONE; DEXAMETHASONE; HIPPOCAMPUS; HORMONE ANTAGONISTS; MALE; MIFEPRISTONE; PITUITARY GLAND; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GLUCOCORTICOID; RECEPTORS, MINERALOCORTICOID; SPIRONOLACTONE;

EID: 0031790351     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(98)00095-8     Document Type: Article

References (53)

1. Dallman M. F., Akana S. F., Cascio C. S., Darlington D. N., Jacobson L., Levin N. Regulation of ACTH secretion: variations on a theme of B. 1987 Recent Prog. Horm. Res. 43:1987;113-173.
2. Herman J. P., Cullinan W. E. Neurocircuitry of stress: central control of the hypothalamo-pituitary-adrenocortical axis. Trends Neurosci. 20:1997;78-84.
3. Arriza J. L., Weinberger C., Cerelli G., Glaser T. M., Handelin B. L., Housman D. E., Evans R. M. Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. Science. 237:1987;268-275.
4. Hollenberg S. M., Weinberger C., Ong E. S., Cerelli G., Oro A., Lebo R., Thompson E. B., Rosenfeld M. G., Evans R. M. Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature. 318:1985;635-641.
5. Reul J. M. H. M., de Kloet E. R. Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. Endocrinology. 117:1985;2505-2511.
6. de Kloet E. R., Oitzl M. S., Joels M. Functional implications of brain corticosteroid receptor diversity. Cell. Mol. Neurobiol. 4:1993;433-455.
7. Perroteau I., Netchitailo P., Delarue C., Leboulenger F., Philibert D., Deraedt R., Hubert V. The effect of the antimineralocorticoid RU28318 on aldosterone biosynthesis in vitro. J. Steroid Biochem. 20:1984;853-856.
8. Sutanto W., de Kloet E. R. ZK91587: a novel synthetic antimineralocorticoid displays high affinity for corticosterone (type I) receptors in the rat hippocampus. Life Sci. 43:1988;1537-1543.
9. Coirini H., Magarinos A. M., De Nicola A. F., Rainbow T. C., McEwen B. S. Further studies of brain aldosterone binding sites employing new mineralocorticoid and glucocorticoid receptor markers in vitro. Brain Res. 361:1985;212-216.
10. Bradbury M. J., Akana S. F., Cascio C. S., Levin N., Jacobson L., Dallman M. F. Regulation of basal ACTH secretion by corticosterone is mediated by both type I (MR) and type II (GR) receptors in rat brain. J. Steroid Biochem. Molec. Biol. 40:1991;133-142.
11. Gruol D. J., Altschmied J. Synergistic induction of apoptosis with glucocorticoids and 3′,5′-cyclic adenosine monophosphate reveals agonist activity by RU486. Mol. Endocrinol. 7:1993;104-113.
12. Laue L., Chrousos G. P., Loriaux D. L., Barnes K., Munson P., Nieman L., Schaison G. The antiglucocorticoid and antiprogestin steroid RU486 suppresses the adrenocorticotropin response to ovine corticotropin releasing hormone in man. J. Clin. Endocrinol. Metab. 66:1988;290-293.
13. Ratka A., Sutanto W., Bloemers M., de Kloet E. R. On the role of brain mineralocorticoid (type I) and glucocorticoid (type II) receptors in neuroendocrine regulation. Neuroendocrinology. 50:1989;117-123.
14. Whelan C. J., Hughes S. C., Wren G. P. A. Inhibition of some aspects of acute inflammation of guinea-pig lung by intraperitoneal dexamethasone and mifepristone: demonstration of agonist activity of mifepristone in the guinea-pig. Inflamm. Res. 44:1995;131-138.
15. Spencer R. L., Miller A. H., Moday H., Stein M., McEwen B. S. Diurnal differences in basal and acute stress levels of type I and type II adrenal steroid receptor activation in neural and immune tissues. Endocrinology. 133:1993;1941-1950.
16. Spencer R. L., Young E. A., Choo P. H., McEwen B. S. Adrenal steroid type I and type II receptor binding: estimates of in vivo receptor number, occupancy and activation with varying level of steroid. Brain Res. 514:1990;37-48.
17. Joels M., De Kloet E. R. Control of neuronal excitability by corticosteroid hormones. Trends Neurosci. 15:1992;25-30.
18. Pavlides C., Watanabe Y., Magarinos A. M., McEwen B. S. Opposing roles of Type I and Type II adrenal steroid receptors in hippocampal long-term potentiation. Neuroscience. 68:1995;387-394.
19. Diamond D. M., Bennett M. C., Fleshner M., Rose G. M. Inverted-U relationship between the level of peripheral corticosterone and the magnitude of hippocampal primed burst potentiation. Hippocampus. 2:1992;421-430.
20. Kuroda U., Watanabe Y., Albeck D. S., Hastings N. B., McEwen B. S. Effects of adrenalectomy and type I or type II glucocorticoid receptor activation on 5-HT1A and 5-HT2 receptor binding and 5-HT transporter mRNA expression in rat brain. Brain Res. 648:1994;157-161.
21. Meijer O. C., Cole T. J., Schmid W., Schutz G., Joels M., de Kloet E. R. Regulation of hippocampal 5-HT1A receptor mRNA and binding in transgenic mice with a targeted disruption of the glucocorticoid receptor. Brain Res. Mol. Brain Res. 46:1997;290-296.
22. Mendelson S. C., McEwen B. S. Autoradiographic analyses of the effects of adrenalectomy and corticosterone on 5-HT1A and 5-HT1B receptors in the dorsal hippocampus and cortex of the rat. Neuroendo. 55:1992;444-450.
23. Watanabe Y., Weiland N. G., McEwen B. S. Effects of adrenal steroid manipulations and repeated restraint stress on dynorphin mRNA levels and excitatory amino acid receptor binding in hippocampus. Brain Res. 680:1995;217-225.
24. Woolley C. S., Gould E., McEwen B. S. Exposure to excess glucocorticoids alters dendritic morphology of adult hippocampal pyramidal neurons. Brain Res. 531:1990;225-231.
25. Gould E., Woolley C. S., Cameron H. A., Daniels D. C., McEwen B. S. Adrenal steroids regulate postnatal development of the rat dentate gyrus. II. Effects of glucocorticoids and mineralocorticoids on cell birth. J. Comp. Neurol. 313:1991;486-493.
26. Woolley C. S., Gould E., Sakai R. R., Spencer R. L., McEwen B. S. Effects of aldosterone or RU28362 treatment on adrenalectomy-induced cell death in the dentate gyrus of the adult rat. Brain Res. 554:1991;312-315.
27. Fregly M. J., Rowland N. E. Role of renin-angiotensin-aldosterone system in NaCl appetite of rats. Am. J. Physiol. 248:1985;R1-R11.
28. Fregly M. J., Waters I. W. Effect of mineralocorticoids on spontaneous sodium chloride appetite of adrenalectomized rats. Physiol. Behav. 1:1966;65-74.
29. McEwen B. S., Lambdin L. T., Rainbow T. C., de Nicola A. F. Aldosterone effects on salt appetite in adrenalectomized rats. Neuroendo. 43:1986;38-43.
30. Sakai R. R., Nicolaidis S., Epstein A. N. Salt appetite is suppressed by interference with angiotensin II and aldosterone. Am. J. Physiol. 251:1986;R762-R768.
31. Magarinos A. M., Coirini H., de Nicola A. F., McEwen B. S. Mineralocorticoid regulation of salt intake is preserved in hippocampectomized rats. Neuroendo. 44:1986;494-497.
32. de Kloet E. R., van der Vies J., de Wied D. The site of suppressive action of dexamethasone on pituitary-adrenal activity. Endocrinology. 94:1974;61-73.
33. Meijer O. C., de Lange E. C. M., Breimer D. D., de Boer A. G., Workel J. O., de Kloet E. R. Penetration of dexamethasone into brain glucocorticoid targets is enhanced in mdr1A P-glycoprotein knockout mice. Endocrinology. 139:1998;1789-1793.
34. Miller A. H., Spencer R. L., Pulera M., Kang S., McEwen B. S., Stein M. Adrenal steroid receptor activation in rat brain and pituitary following dexamethasone: implications for the dexamethasone suppression test. Biol. Psychiatry. 32:1992;850-869.
35. Luttge W. G., Davda M. M., Rupp M. E., Kang C. G. High affinity binding and regulatory actions of dexamethasone-type I receptor complexes in mouse brain. Endocrinology. 125:1989;1194-1203.
36. Schimmer, B. P and Parker, K. L., Adrenocorticotropic hormone; adrenocortical steroids and their synthetic analogs; inhibitors of the synthesis and actions of adrenocortical hormones. In The Pharmacological Basis of Therapeutics, 9th edn, eds J. G. Hardman and L. E. Limbird. McGraw-Hill, New York, 1996, p. 1466, pp. 1459-1485.
37. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 27:1976;248-254.
38. Chou Y. C., Luttge W. G. Activated type II receptors in brain cannot rebind glucocorticoids: relationship to progesterone's antiglucocorticoid actions. Brain Res. 440:1988;67-68.
39. Litwack G. The glucocorticoid receptor at the protein level. Cancer Res. 48:1988;2636-2640.
40. O'Donnell D., Francis D., Weaver S., Meaney M. J. Effects of adrenalectomy and corticosterone placement on glucocorticoid receptor levels in rat brain tissue: a comparison between western blotting and receptor binding assays. Brain Res. 687:1995;133-142.
41. Beck C. A., Estes P. A., Bona B. J., Muro-Cacho C. A., Nordeen S. K., Edwards D. P. The steroid antagonist RU486 exerts different effects on the glucocorticoid and progesterone receptors. Endocrinology. 133:1993;728-740.
42. Meyer A. S., Schmidt T. J. Differential effects of agonists and antagonists on autoregulation of glucocorticoid receptors in a rat colonic adenocarcinoma cell line. J. Steroid Biochem. Molec. Biol. 62:1997;97-105.
43. Pearce, B. D., Pariante, C. M., Pisell, T. L. and Miller, A. H., Mechanism of action of the glucocorticoid receptor antagonist, RU40555. Program of the 26th Annual Meeting of the Society for Neuroscience. Washington D.C., 1996, p. 2013 (Abstract).
44. van Eekelen J. A. M., Kiss J. Z., Westphal H. M., de Kloet E. R. Immunocytochemical study on the intracellular localization of the type 2 glucocorticoid receptor in the rat brain. Brain Res. 436:1987;120-128.
45. Lombes M., Binart N., Delahaye F., Baulieu E. E., Rafestin-Oblin M.-E. Differential intracellular localization of human mineralocorticosteroid receptor on binding of agonists and antagonists. Biochem. J. 302:1994;191-197.
46. Reul J. M. H. M., van den Bosch F. R., de Kloet E. R. Relative occupation of type-I and type-II corticosteroid receptors in rat brain following stress and dexamethasone treatment: functional implications. J. Endocrinol. 115:1987;459-467.
47. Oitzl M.S ., de Kloet E. R. Selective corticosteroid antagonists modulate specific aspects of spatial orientation learning. Behav. Neurosci. 106:1992;62-71.
48. Roozendaal B., McGaugh J. L. Basolateral amygdala lesions block the memory-enhancing effect of glucocorticoid administration in the dorsal hippocampus of rats. Eur. J. Neurosci. 9:1997;76-83.
49. Smythe J. W., Murphy D., Timothy C., Gul G. H. H., Costall B. Cognitive dysfunctions induced by scopolamine are reduced by systemic or intrahippocampal mineralocorticoid receptor blockade. Pharmacol. Biochem. Behav. 56:1997;613-621.
50. Pugh C. R., Fleshner M., Rudy J. W. Type II glucocorticoid receptor antagonists impair contextual but not auditory-cue fear conditioning in juvenile rats. Neurobiol. Learning Mem. 67:1997;75-79.
51. Oitzl M. S., Fluttert M., de Kloet E. R. The effect of corticosterone on reactivity to spatial novelty is mediated by central mineralocorticosteroid receptors. Eur. J. Neurosci. 6:1994;1072-1079.
52. Smythe J. W., Murphy D., Timothy C., Costall B. Hippocampal mineralocorticoid, but not glucocorticoid, receptors modulate anxiety-like behavior in rats. Pharmacol. Biochem. Behav. 56:1997;507-513.
53. de Kloet E. R., de Kock S., Schild V., Veldhuis H. D. Antiglucocorticoid RU 38486 attenuates retention of a behavior and disinhibits the hypothalamic-pituitary adrenal axis at different brain sites. Neuroendocrinology. 47:1988;109-115.